Eli Lilly to pay $2.5B for Scorpion’s lead cancer drug - Boston ...

Eli Lilly To Pay $2.5B For Scorpion’s Lead Cancer Drug - Boston ...

2 weeks from now

1 day ago  · Scorpion Therapeutics Inc. is selling its lead drug in testing for breast cancer and other advanced solid tumors, to Eli Lilly and Co. for up to $2.5 billion.

bizjournals.com

Lilly To Acquire Scorpion Therapeutics' Mutant-selective PI3Kα ...

2 weeks from now

1 day ago  · STX-478 could potentially address 30-40% of people with hormone-positive breast cancer, building on Lilly's advancements against this disease. INDIANAPOLIS and BOSTON, …

lilly.com

Lilly To Pay As Much As $2.5 Billion For Scorpion’s Cancer Drug

2 weeks from now

1 day ago  · Eli Lilly & Co. will pay as much as $2.5 billion in cash to acquire a cancer drug that Scorpion Therapeutics Inc. is testing in early and mid-stage trials.

bloomberg.com

Lilly To Pay As Much As $2.5 Billion For Scorpion’s Cancer Drug

2 weeks from now

1 day ago  · Eli Lilly & Co. will pay as much as $2.5 billion in cash to acquire a cancer drug that Scorpion Therapeutics Inc. is testing in early and mid-stage trials. The purchase includes an …

bloomberglaw.com

Eli Lilly To Acquire Scorpion For Up To $2.5B - MSN

2 weeks from now

Eli Lilly (NYSE:LLY) has agreed to buy Scorpion Therapeutics' lead drug program for up to $2.5B in cash and spin out the remaining company as a new entity focused on precision medicine. …

msn.com

Eli Lilly To Buy Scorpion Therapeutics Drug Program In $2.5 Billion ...

2 weeks from now

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 …

wsj.com

Eli Lilly In Advanced Talks To Buy US Cancer Biotech For Up To $2.5bn

2 weeks from now

4 days ago  · Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn; ... Eli Lilly would pay Boston-based Scorpion about $1bn up front followed by up to $1.5bn at a later date if …

skynews.icu

Eli Lilly In Advanced Talks To Buy US Cancer Biotech For Up To $2.5bn

2 weeks from now

4 days ago  · As part of the proposed terms, Eli Lilly would pay Boston-based Scorpion about $1bn up front followed by up to $1.5bn at a later date if certain performance milestones were met, …

ft.com

Eli Lilly In Talks To Acquire Scorpion Therapeutics, FT Says; Relay ...

2 weeks from now

4 days ago  · Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion. A deal is likely to be reached in the coming …

seekingalpha.com

Eli Lilly In Talks To Acquire Scorpion Therapeutics, FT Says ... - MSN

2 weeks from now

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion. Eli Lilly (NYSE:LLY) is expected to pay around $1 …

msn.com

Watch Bloomberg Open Interest 01/13/2025 - Bloomberg

2 weeks from now

1 day ago  · Katie, let's start with the news that you have out this morning, and that is that Eli Lilly is buying Scorpion Therapeutics breast cancer program for up to $2.5 billion. And I'll start with …

bloomberg.com

Lilly In Advanced Talks To Buy Cancer Biotech Scorpion For Up To …

2 weeks from now

4 days ago  · Under a proposed deal, Lilly would pay Boston-based Scorpion around $1B upfront followed by up to $1.5B at a later date if certain performance milestones are met, said the …

businessinsider.com

Lilly Acquires Scorpion’s Cancer Drug In $2.5 Billion Deal

2 weeks from now

1 day ago  · INDIANAPOLIS and BOSTON - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with a market capitalization of $720 billion and a "GOOD" InvestingPro financial health …

investing.com

Lilly Close To Acquire Cancer Biotech Scorpion Therapeutics For …

2 weeks from now

4 days ago  · Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating …

marketscreener.com

Lilly Acquires Scorpion's Cancer Drug In $2.5 Billion Deal

2 weeks from now

1 day ago  · INDIANAPOLIS and BOSTON - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with a market capitalization of $720 billion and a "GOOD" InvestingPro financial health …

investing.com

Lilly Swoops On Morphic To Claim IBD Drug Candidate

2 weeks from now

Jul 8, 2024  · Eli Lilly boosts its inflammatory bowel disease pipeline with a $3.2bn bid to acquire Morphic and its mid-stage oral integrin therapy. ... Lilly nets Scorpion cancer drug in $2.5bn …

pharmaphorum.com

Lilly Acquires Scorpion's Cancer Drug In $2.5 Billion Deal

2 weeks from now

1 day ago  · INDIANAPOLIS and BOSTON - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with a market capitalization of $720 billion and a "GOOD" InvestingPro financial health …

investing.com